Articles Referencing AMAG
AMAG Narrows Loss; Maintains View - Analyst Blog
4/24/2013, 4:09 pm from Zacks.com in Investing, Business, Stocks
AMAG Pharmaceuticals Inc. 's ( AMAG ) first quarter
2013 loss of 19 cents per share was narrower than the year-ago loss
of 58 cents and the Zacks Consensus Estimate of a loss of 20... Read >>
Positive Results on AMAG's Feraheme - Analyst Blog
3/18/2013, 6:47 pm from Zacks.com in Investing, Business, Stocks
AMAG Pharmaceuticals Inc. ( AMAG ) recently
announced positive preliminary results from the IDA-303 study on
Feraheme (ferumoxytol). The IDA-303 study evaluated the safety and
efficacy of... Read >>
FDA Action Date for AMAG Drug - Analyst Blog
3/11/2013, 6:27 pm from Zacks.com in Investing, Business, Stocks
AMAG Pharmaceuticals, Inc. ( AMAG ) recently
announced that its supplemental new drug application (sNDA) for
Feraheme (ferumoxytol) has been accepted by the US Food and Drug
Administration... Read >>
AMAG Narrows Loss, Maintains View - Analyst Blog
3/4/2013, 1:39 pm from Zacks.com in Investing, Business, Stocks
AMAG Pharmaceuticals Inc. 's ( AMAG ) fourth quarter
2012 loss of 14 cents per share was narrower than the year-ago loss
of 71 cents but wider than the Zacks Consensus Estimate of a loss
of... Read >>
AMAG Gives 4Q12 Snapshot - Analyst Blog
1/7/2013, 6:20 pm from Zacks.com in Investing, Business, Stocks
AMAG Pharmaceuticals ( AMAG )
recently announced its preliminary fourth quarter 2012 financial
results and its guidance for 2013. The company's total revenue for
2012 is expected to be... Read >>
AMAG Seeks Feraheme Label Expansion - Analyst Blog
12/27/2012, 3:40 pm from Zacks.com in Investing, Business, Stocks
AMAG Pharmaceuticals ( AMAG )
recently submitted a supplemental new drug application (sNDA) to
the US Food and Drug Administration (FDA) for the intravenous (IV)
dose of Feraheme... Read >>
Pre-Market Earnings Report for July 26, 2012 : MMM, PLD, AGCO, ABB, ALK, ALKS, DDD, ASPS, ACIW, AIXG, ALU, AMAG
7/25/2012, 4:08 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings prior to
market open on 07/26/2012. Visit our Earnings
Calendar for a full list of expected earnings releases. 3M Company ( MMM ) is... Read >>
China's Slashed Growth Forecast Weighs on Stock Futures
3/5/2012, 8:30 am from Schaeffer's Investment Research in Investing, Options
Wall Street is taking a cautious stance ahead of today's
session, with futures on all three major market indexes pointed
south of breakeven. International news has edged its way back into
the... Read >>
Allos Continues to Outperform - Analyst Blog
11/25/2011, 12:15 pm from Zacks.com in Investing, Business, Stocks
We are maintaining our Outperform recommendation on
Allos Therapeutics Inc.
(
ALTH)
following the announcement of decent third quarter 2011 results by
the company.
Allos... Read >>
AMAG Hires Financial Advisor - Analyst Blog
11/18/2011, 1:00 pm from Zacks.com in Investing, Business, Stocks
AMAG Pharmaceuticals Inc.
(
AMAG
) recently announced that it has hired
Jefferies & Company, Inc.
(
JEF
) as financial advisor to help it evaluate strategic... Read >>
Options Ideas: 24 Healthcare Stocks With Bullish Options Sentiment
6/7/2011, 1:15 pm from Kapitall in Investing, Investing Ideas, Stocks
Are you looking to boost your exposure to the healthcare sector? If so, this may be an interesting starting point for you own analysis. To construct this list we looked for stocks with three... Read >>
4 Biotech Stocks That Could Pop
5/18/2011, 9:00 am from David Sterman in Investing, Investing Ideas
When analysts received word on March 30 that
Medicare
would cover
Dendreon's (Nasdaq:
DNDN
)
pricey drug Provenge, used to treat prostate cancer,
shares
of the drug maker steadily... Read >>
A 'Buy' Signal for Biotech's Best Value Play
11/30/2010, 6:59 am from David Sterman in Investing, Investing Ideas
When the entire value of a company shrinks down to the amount of
cash on its balance sheet , you know investors have lost all
interest. For
AMAG Pharma (Nasdaq:
AMAG
)
, that's precisely... Read >>
Looking for Value in September's Biggest Losers
10/4/2010, 11:42 am from David Sterman in Investing, Investing Ideas
With reward comes risk. That's the painful lesson learned by
biotech investors last month. Investors in
Arena Pharma (Nasdaq: ARNA)
,
Idenix Pharma (Nasdaq: IDIX)
,
AMAG Pharma (Nasdaq:... Read >>
Options Trade of the Day: A Ratio Call Spread on AMAG Pharmaceuticals Inc.
9/27/2010, 3:13 pm from Schaeffer's Investment Research in Investing, Options
AMAG Pharmaceuticals Inc. (
AMAG
) is quite popular among call traders today, with volume swelling
to more than 4,200 contracts. Compared to the stock's average daily
call volume of just 219... Read >>